Jefferies Group LLC Sage Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Sep 21, 2023	BUY	$37.06 - $47.11 $355,776 - $452,256	9,600 Added 9600.0%	9,700 $412,000
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $355,776 - $452,256	9,600 Added 9600.0%	9,700 $413,000
Q3 2021 Sep 21, 2023	SELL	$40.26 - $57.37 $1.44 Million - $2.05 Million	-35,800 Reduced 99.72%	100 $4,000
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $1.44 Million - $2.05 Million	-35,800 Reduced 99.72%	100 $4,000
Q2 2021 Sep 21, 2023	SELL	$54.88 - $79.29 $1.15 Million - $1.66 Million	-20,900 Reduced 36.8%	35,900 $2.04 Million

Q2 2021 Aug 20, 2021	SELL	$54.88 - $79.29 $195 Million - $282 Million	-3,554,100 Reduced 99.0%	35,900 $2.04 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $194 Million - $280 Million	3,533,200 Added 6220.42%	3,590,000 $2.04 Million
Q1 2021 Sep 21, 2023	BUY	$70.65 - $96.76 $1.26 Million - $1.73 Million	17,900 Added 46.02%	56,800 $4.25 Million
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $1.26 Million - $1.73 Million	17,900 Added 46.02%	56,800 $4.25 Million
Q4 2020 Sep 21, 2023	BUY	$58.41 - $89.06 $2.27 Million - $3.46 Million	38,900 New	38,900 $3.37 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $1.88 Million - $2.87 Million	32,200 Added 480.6%	38,900 $3.37 Million
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $2.41 Million - $3.67 Million	-58,700 Reduced 89.76%	6,700 $410,000
Q4 2019 Feb 13, 2020	SELL	$60.18 - $154.77 $583,746 - $1.5 Million	-9,700 Reduced 12.92%	65,400 $4.72 Million
Q3 2019 Nov 13, 2019	BUY	$140.29 - $189.96 $1.74 Million - $2.36 Million	12,400 Added 19.78%	75,100 $10.5 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $3.43 Million - $3.97 Million	-21,700 Reduced 25.71%	62,700 $11.5 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $6.25 Million - $11.5 Million	70,000 Added 486.11%	84,400 $13.4 Million
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $1.18 Million - $2.01 Million	14,400 New	14,400 $1.38 Million

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$62 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$59.1 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$52.7 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$51.2 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$48.5 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account